Trial Profile
Phase I study of ALX-0761 for the treatment of inflammatory diseases
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 13 Jun 2014
Price :
$35
*
At a glance
- Drugs Sonelokimab (Primary)
- Indications Inflammation; Psoriasis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 13 Jun 2014 New trial record